These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8912206)

  • 1. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection.
    Gessain A
    J Neurovirol; 1996 Oct; 2(5):299-306. PubMed ID: 8912206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.
    Tanaka M; Takenouchi N; Arishima S; Matsuzaki T; Nozuma S; Matsuura E; Takashima H; Kubota R
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalanced IL10/TGF-β production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis.
    Gois LL; Ribeiro-Soares B; Regis-Silva CG; Zanette DL; Lisboa R; Nascimento RS; Coutinho Junior R; Galvão-Castro B; Grassi MFR
    BMC Infect Dis; 2024 Jun; 24(1):652. PubMed ID: 38943078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.
    Souza FDS; Freitas NL; Gomes YCP; Torres RC; Echevarria-Lima J; da Silva-Filho IL; Leite ACCB; de Lima MASD; da Silva MTT; Araújo AQC; Espíndola OM
    Front Immunol; 2021; 12():737941. PubMed ID: 34764955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease.
    Yakova M; Lézin A; Dantin F; Lagathu G; Olindo S; Jean-Baptiste G; Arfi S; Césaire R
    Retrovirology; 2005 Feb; 2():4. PubMed ID: 15686595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.
    Morgan DJ; Caskey MF; Abbehusen C; Oliveira-Filho J; Araujo C; Porto AF; Santos SB; Orge GO; Joia MJ; Muniz AL; Siqueira I; Glesby MJ; Carvalho E
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1499-504. PubMed ID: 18160007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy.
    Taylor GP; Hall SE; Navarrete S; Michie CA; Davis R; Witkover AD; Rossor M; Nowak MA; Rudge P; Matutes E; Bangham CR; Weber JN
    J Virol; 1999 Dec; 73(12):10289-95. PubMed ID: 10559346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Ahmadi Ghezeldasht S; Mosavat A; Rezaee SA
    Rev Med Virol; 2024 Jul; 34(4):e2567. PubMed ID: 38937135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.
    Yamano Y; Takenouchi N; Li HC; Tomaru U; Yao K; Grant CW; Maric DA; Jacobson S
    J Clin Invest; 2005 May; 115(5):1361-8. PubMed ID: 15864353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
    Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
    PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
    Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
    Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel complications with HTLV-1-associated myelopathy/tropical spastic paraparesis: interstitial cystitis and persistent prostatitis.
    Nomata K; Nakamura T; Suzu H; Yushita Y; Kanetake H; Sawada T; Ikeda S; Hino S; Nagataki S; Saito Y
    Jpn J Cancer Res; 1992 Jun; 83(6):601-8. PubMed ID: 1353753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1-associated myelopathy.
    Maher AK; Aristodemou A; Giang N; Tanaka Y; Bangham CR; Taylor GP; Dominguez-Villar M
    JCI Insight; 2024 Jan; 9(1):. PubMed ID: 38193535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.
    Terada Y; Kamoi K; Ohno-Matsui K; Miyata K; Yamano C; Coler-Reilly A; Yamano Y
    Medicine (Baltimore); 2017 Feb; 96(6):e6021. PubMed ID: 28178142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases.
    Pleet ML; Welsh JA; Stack EH; Cook S; Johnson DA; Killingsworth B; Traynor T; Clauze A; Hughes R; Monaco MC; Ngouth N; Ohayon J; Enose-Akahata Y; Nath A; Cortese I; Reich DS; Jones JC; Jacobson S
    Front Immunol; 2023; 14():1235791. PubMed ID: 37622115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic Paraplegias.
    Takao N; Yagishita N; Araya N; Aratani S; Yamauchi J; Takahashi K; Kunitomo Y; Sato T; Nakamori M; Kawai Y; Omae Y; Tokunaga K; Matsuda F; Mitsuhashi S; Yamano Y
    Neurol Genet; 2024 Feb; 10(1):e200108. PubMed ID: 38716326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular autophagy pathway modulates human T-cell leukemia virus type 1 replication.
    Tang SW; Chen CY; Klase Z; Zane L; Jeang KT
    J Virol; 2013 Feb; 87(3):1699-707. PubMed ID: 23175371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.
    Kannagi M; Hasegawa A; Takamori A; Kinpara S; Utsunomiya A
    Front Microbiol; 2012; 3():323. PubMed ID: 22969761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1.
    Ooms M; Krikoni A; Kress AK; Simon V; Münk C
    J Virol; 2012 Jun; 86(11):6097-108. PubMed ID: 22457529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.
    Andresen V; Pise-Masison CA; Sinha-Datta U; Bellon M; Valeri V; Washington Parks R; Cecchinato V; Fukumoto R; Nicot C; Franchini G
    Blood; 2011 Aug; 118(6):1549-59. PubMed ID: 21677314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.